Bank of America Upgrades AbbVie (ABBV) on Skyrizi Strength, Lifts PT
Summary
On April 30, Bank of America analyst Tim Anderson upgraded AbbVie Inc. (NYSE:ABBV) to Buy from Neutral. It also lifted the price target on the stock to $234 fro...
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.